The 118–135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion

1997 ◽  
Vol 274 (3) ◽  
pp. 381-393 ◽  
Author(s):  
Thierry Pillot ◽  
Laurence Lins ◽  
Marc Goethals ◽  
Berlinda Vanloo ◽  
Johan Baert ◽  
...  
1998 ◽  
Vol 335 (2) ◽  
pp. 369-374 ◽  
Author(s):  
Mar PÉREZ ◽  
Francisco WANDOSELL ◽  
Camilo COLAÇO ◽  
Jesús AVILA

Although a number of features distinguish the disease isoform of the prion protein (PrPSc) from its normal cellular counterpart (PrPC) in the transmissible spongiform encephalopathies (TSEs), the neuropathogenesis of these diseases remains an enigma. The amyloid fibrils formed by fragments of human PrP have, however, been shown to be directly neurotoxic in vitro. We show here that sulphated polysaccharides (heparin, keratan and chondroitin) inhibit the neurotoxicity of these amyloid fibrils and this appears to be mediated via inhibition of the polymerization of the PrP peptide into fibrils. This provides a rationale for the therapeutic effects of sulphated polysaccharides and suggests a rapid in vitro functional screen for TSE therapeutics.


2010 ◽  
Vol 16 (18) ◽  
pp. 5492-5499 ◽  
Author(s):  
Ni-Shian Lin ◽  
John Ching-Hao Chao ◽  
Hsin-Mei Cheng ◽  
Fang-Chieh Chou ◽  
Chi-Fon Chang ◽  
...  

2021 ◽  
Author(s):  
Qiuye Li ◽  
Christopher P. Jaroniec ◽  
Witold K. Surewicz

One of the least understood aspects of prion diseases is the structure of infectious prion protein aggregates. Here we report a high-resolution cryo-EM structure of amyloid fibrils formed by human prion protein with Y145Stop mutation that is associated with a familial prion disease. This structural insight allows us not only to explain previous biochemical findings, but also provides direct support for the conformational adaptability model of prion transmissibility barriers.


2006 ◽  
Vol 87 (8) ◽  
pp. 2443-2449 ◽  
Author(s):  
Patrick A. Lewis ◽  
M. Howard Tattum ◽  
Samantha Jones ◽  
Daljit Bhelt ◽  
Mark Batchelor ◽  
...  

The human prion protein (PrP) has a common polymorphism at residue 129, which can be valine or methionine. This polymorphism has a strong influence on susceptibility to prion diseases and on prion-strain properties. Previous work has shown that this amino acid variation has no measurable effect on the native structure of cellular PrP (PrPC). Here, it is shown that the polymorphism does not change the efficiency of conversion to the β-PrP conformation or affect the binding of copper(II) ions. However, in a partially denatured conformation, the polymorphic variation has a profound influence on the ability of the protein to form amyloid fibrils spontaneously.


Structure ◽  
2009 ◽  
Vol 17 (3) ◽  
pp. 417-426 ◽  
Author(s):  
Patrick Walsh ◽  
Karen Simonetti ◽  
Simon Sharpe

Prion ◽  
2009 ◽  
Vol 3 (4) ◽  
pp. 224-235 ◽  
Author(s):  
Karin Almstedt ◽  
Sofie Nyström ◽  
K. Peter R. Nilsson ◽  
Per Hammarström

2011 ◽  
Vol 133 (35) ◽  
pp. 13934-13937 ◽  
Author(s):  
Jonathan J. Helmus ◽  
Krystyna Surewicz ◽  
Marcin I. Apostol ◽  
Witold K. Surewicz ◽  
Christopher P. Jaroniec

Sign in / Sign up

Export Citation Format

Share Document